Genomiki
1 known investors
Find your way into Genomiki
Sign up to see every warm intro you have to Genomiki
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Genomiki team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Genomiki develops AI/ML- and genomics-driven diagnostic, screening, and microbiome analysis tools that convert sequencing and clinical data into insights for early risk detection and personalized interventions. Its solutions are designed to integrate into clinical and wellness workflows to support medical decisions and research.
Investors · 1
Frequently asked questions
- What does Genomiki do?
- Genomiki develops AI/ML- and genomics-driven diagnostic, screening, and microbiome analysis tools that convert sequencing and clinical data into insights for early risk detection and personalized interventions. Its solutions are designed to integrate into clinical and wellness workflows to support medical decisions and research.
- Who are Genomiki's investors?
- Genomiki's investors include PointOne Capital.